These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25394491)
21. Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis. Kelleher I; Murtagh A; Clarke MC; Murphy J; Rawdon C; Cannon M Cogn Neuropsychiatry; 2013; 18(1-2):9-25. PubMed ID: 22991935 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981 [TBL] [Abstract][Full Text] [Related]
23. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition. Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463 [TBL] [Abstract][Full Text] [Related]
24. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report. Carandang CG; Scholten MC J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559 [TBL] [Abstract][Full Text] [Related]
29. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome. Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720 [TBL] [Abstract][Full Text] [Related]
30. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790 [TBL] [Abstract][Full Text] [Related]
31. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Kates WR; Krauss BR; Abdulsabur N; Colgan D; Antshel KM; Higgins AM; Shprintzen RJ Neuropsychologia; 2007 Sep; 45(12):2863-73. PubMed ID: 17618656 [TBL] [Abstract][Full Text] [Related]
32. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome. Moore TM; Salzer D; Bearden CE; Calkins ME; Kates WR; Kushan L; Gallagher RS; Frumer DS; Weinberger R; McDonald-McGinn DM; Gur RE; Gothelf D J Neurodev Disord; 2021 Jun; 13(1):23. PubMed ID: 34126928 [TBL] [Abstract][Full Text] [Related]
34. Early prodromal symptoms can predict future psychosis in familial high-risk youth. Tandon N; Montrose D; Shah J; Rajarethinam RP; Diwadkar VA; Keshavan MS J Psychiatr Res; 2012 Jan; 46(1):105-10. PubMed ID: 22056319 [TBL] [Abstract][Full Text] [Related]
35. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154 [TBL] [Abstract][Full Text] [Related]
36. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome). Jolin EM; Weller RA; Weller EB Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762 [TBL] [Abstract][Full Text] [Related]
37. The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology. Lajiness-O'Neill R; Beaulieu I; Asamoah A; Titus JB; Bawle E; Ahmad S; Kirk JW; Pollack R Arch Clin Neuropsychol; 2006 Feb; 21(2):175-84. PubMed ID: 16307864 [TBL] [Abstract][Full Text] [Related]